Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapyBonanno, L. ; Costa, C. ; Majem, M. ; Favaretto, A. ; Rugge, M. ; Rosell, R.Annals of oncology, 2013-04, Vol.24 (4), p.1130-1132 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
Sorafenib in combination with erlotinib or with gemcitabine in elderly patients with advanced non-small-cell lung cancer: a randomized phase II studyGridelli, C. ; Morgillo, F. ; Favaretto, A. ; de Marinis, F. ; Chella, A. ; Cerea, G. ; Mattioli, R. ; Tortora, G. ; Rossi, A. ; Fasano, M. ; Pasello, G. ; Ricciardi, S. ; Maione, P. ; Di Maio, M. ; Ciardiello, F.Annals of oncology, 2011-07, Vol.22 (7), p.1528-1534 [Periódico revisado por pares]Oxford: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
Compliance to diagnostic and therapeutic pathways and innovative drug recommendations in advanced non-small cell lung cancer: preliminary results from the MOST studyPasello, G. ; Vicario, G. ; Gori, S. ; Zustovich, F. ; Bonetti, A. ; Rosetti, F. ; Favaretto, A. ; Oniga, F. ; Bria, E. ; Toso, S. ; Boccalon, M. ; Oliani, C. ; Palazzolo, G. ; Frega, S. ; Basso, M. ; Pertile, P. ; Bortolami, A. ; Verrienti, R. ; Scanni, R. ; Conte, P.Annals of oncology, 2017-10, Vol.28, p.vi57-vi57 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
Negative prognostic factors and resulting clinical outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) included in the Italian nivolumab expanded access program (EAP)Bracarda, S. ; Galli, L. ; Maruzzo, M. ; Lo Re, G. ; Buti, S. ; Favaretto, A. ; Costanzo, F.D. ; Sacco, C. ; Merlano, M. ; Mucciarini, C. ; Zafarana, E. ; Romito, S. ; Maestri, A. ; Giannitto Giorgio, C. ; Ionta, M.T. ; Turci, D. ; De Giorgi, U. ; Procopio, G. ; Cortesi, E. ; Porta, C.Annals of oncology, 2017-09, Vol.28, p.v314-v314 [Periódico revisado por pares]Elsevier LtdTexto completo disponível |
|
5 |
Material Type: Artigo
|
Are PubMed alone and English literature only enough for a meta-analysis?Zheng, B. ; Zheng, W. ; Zhu, Y. ; Guo, C. ; Wu, W. ; Chen, C.Annals of oncology, 2013-04, Vol.24 (4), p.1130-1130 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
6 |
Material Type: Artigo
|
Symptomatic Toxicities Experienced During Anti-Cancer Treatment: Comparison of Patients' and Physicians' Reporting in Three Randomized Controlled Trials (Rcts)Di Maio, M. ; Piccirillo, M.C. ; Daniele, G. ; Nuzzo, F. ; Gridelli, C. ; Gebbia, V. ; Ciardiello, F. ; De Placido, S. ; Ceribelli, A. ; Favaretto, A. ; De Matteis, A. ; Feld, R. ; Butts, C.A. ; Leighl, N.B. ; Morabito, A. ; Bryce, J. ; Signoriello, S. ; Gallo, C. ; Perrone, F.Annals of oncology, 2014-09, Vol.25, p.iv517 [Periódico revisado por pares]Texto completo disponível |
|
7 |
Material Type: Artigo
|
Epidermal Growth Factor Receptor (Egfr) and Abcg2 Polymorphisms and Treatment Outcome in the Randomized Phase III Torch Trial in Advanced Non-Small Cell Lung Cancer (Nsclc) PatientsLiu, G. ; Di Maio, M. ; Tsao, M. ; Cheng, D. ; Chen, Z. ; Wierzbicki, R. ; Riccardi, F. ; Spatafora, M. ; Adamo, V. ; Favaretto, A. ; Bianco, R. ; Gregg, R.W. ; Costanzo, R. ; Signoriello, S. ; Butts, C.A. ; Ciardiello, F. ; Feld, R. ; Gallo, C. ; Gridelli, C. ; Perrone, F.Annals of oncology, 2014-09, Vol.25, p.iv438 [Periódico revisado por pares]Texto completo disponível |
|
8 |
Material Type: Artigo
|
1250PEPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND ABCG2 POLYMORPHISMS AND TREATMENT OUTCOME IN THE RANDOMIZED PHASE III TORCH TRIAL IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTSLiu, G. ; Di Maio, M. ; Tsao, M. ; Cheng, D. ; Chen, Z. ; Wierzbicki, R. ; Riccardi, F. ; Spatafora, M. ; Adamo, V. ; Favaretto, A. ; Bianco, R. ; Gregg, R.W. ; Costanzo, R. ; Signoriello, S. ; Butts, C.A. ; Ciardiello, F. ; Feld, R. ; Gallo, C. ; Gridelli, C. ; Perrone, F.Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv438-iv438 [Periódico revisado por pares]Oxford University PressTexto completo disponível |
|
9 |
Material Type: Artigo
|
1480OSYMPTOMATIC TOXICITIES EXPERIENCED DURING ANTI-CANCER TREATMENT: COMPARISON OF PATIENTS' AND PHYSICIANS' REPORTING IN THREE RANDOMIZED CONTROLLED TRIALS (RCTS)Di Maio, M. ; Piccirillo, M.C. ; Daniele, G. ; Nuzzo, F. ; Gridelli, C. ; Gebbia, V. ; Ciardiello, F. ; De Placido, S. ; Ceribelli, A. ; Favaretto, A. ; De Matteis, A. ; Feld, R. ; Butts, C.A. ; Leighl, N.B. ; Morabito, A. ; Bryce, J. ; Signoriello, S. ; Gallo, C. ; Perrone, F.Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv517-iv517 [Periódico revisado por pares]Oxford University PressTexto completo disponível |
|
10 |
Material Type: Artigo
|
A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trialDaniele, G. ; Morabito, A. ; Favaretto, A. ; Filipazzi, V. ; Rossi, A. ; Gebbia, V. ; Castiglione, F. ; Cavanna, L. ; Maiello, E. ; Valmadre, G. ; Costanzo, R. ; Manzo, A. ; Bonanno, L. ; Piazza, E. ; Maione, P. ; Mancuso, G. ; Di Maio, M. ; Piccirillo, M.C. ; Gallo, C. ; Perrone, F. ; Gridelli, C.Annals of oncology, 2015-10, Vol.26, p.vi73 [Periódico revisado por pares]Texto completo disponível |